Michael P. Arend,Lee A. Flippin,Volkmar Guenzler-Pukall,Wen-Bin Ho,Eric D. Turtle,Xiaohui Du
申请号：
US15133104
公开号：
US20170035747A1
申请日:
2016.04.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
